CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Learn more about:
Related Clinical Trial
Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor